Randomised clinical trial: mesalazine versus placebo in the prevention of diverticulitis recurrence.

W KruisV KardalinosT EisenbachM LukasT VichI BunganicJ PokrotnieksJ DerovaJ KondrackieneR SafadiD TuculanuZ TulassayJ BanaiA CurtinA E DorofeyevS F ZakkoN FerreiraS BjörckM M Diez AlonsoJ MäkeläN J TalleyK DilgerR GreinwaldRalf MohrbacherR Spiller

Published in: Alimentary pharmacology & therapeutics (2017)

Mesalazine was not superior to placebo in preventing recurrence of diverticulitis.

Keyphrases

double blind
clinical trial
phase iii
placebo controlled
open label
free survival
phase ii
study protocol
randomized controlled trial